The Median of Progression free survival in Patients with HR+/HER2− Metastatic Breast Cancer Treated with Initial Endocrine Therapy in Eastern Algeria. A prospective study.

Background. Endocrine therapy became the standard in the management of metastatic luminal breast cancer without visceral crisis, and which has proven its effectiveness in terms of PFS (Progression free survival) and OS (overall survival). Although the recommendations are not perfectly applied, an...

Full description

Bibliographic Details

Published in:	Batna Journal of Medical Sciences
Main Authors:	Asma BOUDERSA, Nassima KOUADRI, Taha FILALI
Format:	Article
Language:	Arabic
Published:	Algerian Society of Clinical & Oncological Pharmacy 2025-06-01
Subjects:	endocrine therapy first line metastatic breast cancer hormone receptor positive.
Online Access:	https://batnajms.net/wp-content/uploads/Archives/2025/2/BJMS_Boudersa.pdf